We haveenough cashto go wellinto 2023I/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialWe willhaveexclusivityI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersInsidersinvested$26.5mI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsNot manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Our Halo-Lido trial willhave finalpatient byend of 2022Hemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We expect tofinish theMino-Loktrial this yearMino-WrapMino-Lokis our leadassetMino-Lokpotentialmarket>$1BI'm ashareholdermyselfAn actualiMSCupdateWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe will openupinternationalsites forMino-Lok trialWe willhaveexclusivityI/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersInsidersinvested$26.5mI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsNot manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Our Halo-Lido trial willhave finalpatient byend of 2022Hemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We expect tofinish theMino-Loktrial this yearMino-WrapMino-Lokis our leadassetMino-Lokpotentialmarket>$1BI'm ashareholdermyselfAn actualiMSCupdate

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We have enough cash to go well into 2023
  2. I/ONTAK is our lead asset
  3. We had a phase 2b trial with 100% efficacy
  4. We will open up international sites for Mino-Lok trial
  5. We will have exclusivity
  6. I/ONTAK's potential market is >$300m
  7. I won't dilute shareholders
  8. Insiders invested $26.5m
  9. I/ONTAK was the best deal I ever made
  10. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  11. Myron Holubiak and I founded a private company in 2013
  12. There are no FDA approved drugs to treat hemorrhoids
  13. Not many companies this size with 2 late stage assets
  14. Only biotech with 2 Myron's on the leadership team
  15. We intend to submit a BLA in 2H 2022
  16. Our Halo-Lido trial will have final patient by end of 2022
  17. Hemorrhoids is a $2B market
  18. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  19. We expect to finish the Mino-Lok trial this year
  20. Mino-Wrap
  21. Mino-Lok is our lead asset
  22. Mino-Lok potential market >$1B
  23. I'm a shareholder myself
  24. An actual iMSC update